ProductLife Group acquires RNI, expanding its scientific and regulatory offering to selfcare products
Learn MoreProductLife Group announces its intention to merge with Pharma D&S Group, expanding its overall offering and italian footprint
Learn MoreProductLife Group Acquires Cilatus and Expands Expertise on Complex Products Development
Learn MoreRegulatory Affairs
Regulatory operations
Pharma IT Solutions
Quality & Compliance
Safety & Vigilance
Medical devices
04 august 2022
Small European based Research and Development company intending to develop and register their first NCE targeting Non-Alcoholic Fatty Liver Disease (NAFLD) & Steatohepatitis (NASH).
This drug was not authorised anywhere in the world.
Go to our Events to register
Go to our News to get insights